This week, we have a conversation with Jeff Fischer, president of Longhorn Vaccines & Diagnostics, and with Hannah Amies, founder and CEO of Luvida.

Times:

03:03 Longhorn Vaccines and Diagnostics

25:03 Luvida

Longhorn Vaccines & Diagnostics on breakthroughs in molecular testing

Maryland-based Longhorn Vaccines and Diagnostics is a IND-enabling stage biopharmaceutical company developing vaccines, monoclonal antibodies, and diagnostics targeting pathogens.

The company focuses on innovative approaches to addressing major public health challenges including antimicrobial resistance, sepsis, and inflammatory disease.

Started in 2006 with the invention of inactivating molecular transport media for collection of r ...